Related references
Note: Only part of the references are listed.An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction
Everardo Macias et al.
CANCER CELL (2010)
Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53
Chad Deisenroth et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Proprotein Convertase Inhibition Results in Decreased Skin Cell Proliferation, Tumorigenesis, and Metastasis
Daniel E. Bassi et al.
NEOPLASIA (2010)
Signaling to p53: Ribosomal Proteins Find Their Way
Yanping Zhang et al.
CANCER CELL (2009)
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation
Mikael S. Lindstrom et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter
O Ayrault et al.
EXPERIMENTAL CELL RESEARCH (2006)
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis
R Hill et al.
CELL (2005)
Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model
R Hill et al.
CANCER RESEARCH (2005)
Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development
SS Grewal et al.
NATURE CELL BIOLOGY (2005)
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
A Arabi et al.
NATURE CELL BIOLOGY (2005)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
Inhibition of HDM2 and activation of p53 by ribosomal protein L23
A Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition
MS Dai et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
DC Fingar et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5
MS Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size
P Jorgensen et al.
GENES & DEVELOPMENT (2004)
Regulation of HDM2 activity by the ribosomal protein L11
MAE Lohrum et al.
CANCER CELL (2003)
Direct activation of RNA polymerase III transcription by c-Myc
N Gomez-Roman et al.
NATURE (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes
A Menssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo
D Tolbert et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
AW Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
P19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes
E Roper et al.
EMBO REPORTS (2001)
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
HA Coller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)